Genetic Newborn Screening for Cystinosis and Primary Hyperoxaluria — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Genetic Newborn Screening for Cystinosis and Primary Hyperoxaluria — Stella

Home/Cystinosis/

View on ClinicalTrials.gov

Recruiting

Back to Cystinosis trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Germany

Screening Laboratory Hanover, Hanover, Lower Saxony

Key details

Sponsor

Cystinose Stiftung

Collaborators

Screening Laboratory Hannover, Pediatry Kastanienhof Koeln

Enrollment target

~200,000 participants

Started

March 2022

Primary completion

December 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

32 Hours – 72 Hours

Last updated May 2023

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.